• Home
  • About
  • Browse
  • Help
  • Download

Plant Name: Diphylleia sinensis


Taxonomic Information:

Plant ID: NPO26868
Plant Latin Name: Diphylleia sinensis
Taxonomy Genus: Diphylleia
Taxonomy Family: Berberidaceae

Plant External Links:

NCBI TaxonomyDB: 382113
Plant-of-the-World-Online: n.a.


Used in Medicines:

Country/Region:
China

Traditional Medicine System:
TCM


Medicinal Functions:

Antiseptic; Cancer


Geographical Distribution:

China

Geographical Distribution
See the Plant Occurrence Worldwide with Latitude and Longitude Available



Collective Molecular Activities of the Plant

List of Human Proteins Collectively Targeted by the Plant

Target Activity Range: ≤ 10μM
Click Gene ID to Access Activity Profile of Individual Target
Target Class
Target Proteins
Peptide receptor (family A GPCR)
NPSR1;
Enzyme_unclassified
CTDSP1; TDP1; HSD17B1; AKR1B1; HSD17B2; ALOX15; NOX4;
Protein Kinase
DAPK1; FLT3;
Lyase
CA2; CA12; CA7;
Nuclear hormone receptor subfamily 3 group C
AR;
Nuclear hormone receptor subfamily 3 group B
ESRRA;
Oxidoreductase
ALOX5; TYR; XDH;
Transcription Factor
AHR; HIF1A; TP53;
ATP-binding cassette
ABCG2; ABCC1;
Unclassified
HTT; LMNA;


List of Human Cytochrome P450 Enzymes Affected by the Plant

Activity Range: ≤ 10μM
Click Gene ID to Access Activity Profile of Individual Enzyme
Cytochrome P450 Enzymes: CYP2C19; CYP2C9; CYP1A2; CYP1B1; CYP1A1;

Detailed Information of Target Proteins

Protein Class Gene ID Protein Name Uniprot ID Target ChEMBL ID
ATP-binding cassette ABCG2 ATP-binding cassette sub-family G member 2 Q9UNQ0 CHEMBL5393
ATP-binding cassette ABCC1 Multidrug resistance-associated protein 1 P33527 CHEMBL3004
Cytochrome P450 family 1 CYP1A2 Cytochrome P450 1A2 P05177 CHEMBL3356
Cytochrome P450 family 1 CYP1B1 Cytochrome P450 1B1 Q16678 CHEMBL4878
Cytochrome P450 family 1 CYP1A1 Cytochrome P450 1A1 P04798 CHEMBL2231
Cytochrome P450 family 2 CYP2C19 Cytochrome P450 2C19 P33261 CHEMBL3622
Cytochrome P450 family 2 CYP2C9 Cytochrome P450 2C9 P11712 CHEMBL3397
Enzyme_unclassified CTDSP1 Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 Q9GZU7 CHEMBL1795098
Enzyme_unclassified TDP1 Tyrosyl-DNA phosphodiesterase 1 Q9NUW8 CHEMBL1075138
Enzyme_unclassified HSD17B1 Estradiol 17-beta-dehydrogenase 1 P14061 CHEMBL3181
Enzyme_unclassified AKR1B1 Aldose reductase P15121 CHEMBL1900
Enzyme_unclassified HSD17B2 Estradiol 17-beta-dehydrogenase 2 P37059 CHEMBL2789
Enzyme_unclassified ALOX15 Arachidonate 15-lipoxygenase P16050 CHEMBL2903
Enzyme_unclassified NOX4 NADPH oxidase 4 Q9NPH5 CHEMBL1250375
Lyase CA2 Carbonic anhydrase II P00918 CHEMBL205
Lyase CA12 Carbonic anhydrase XII O43570 CHEMBL3242
Lyase CA7 Carbonic anhydrase VII P43166 CHEMBL2326
Nuclear hormone receptor subfamily 3 group B ESRRA Estrogen-related receptor alpha P11474 CHEMBL3429
Nuclear hormone receptor subfamily 3 group C AR Androgen Receptor P10275 CHEMBL1871
Oxidoreductase ALOX5 Arachidonate 5-lipoxygenase P09917 CHEMBL215
Oxidoreductase TYR Tyrosinase P14679 CHEMBL1973
Oxidoreductase XDH Xanthine dehydrogenase P47989 CHEMBL1929
Peptide receptor (family A GPCR) NPSR1 Neuropeptide S receptor Q6W5P4 CHEMBL5162
Protein Kinase DAPK1 Death-associated protein kinase 1 P53355 CHEMBL2558
Protein Kinase FLT3 Tyrosine-protein kinase receptor FLT3 P36888 CHEMBL1974
Transcription Factor AHR Aryl hydrocarbon receptor P35869 CHEMBL3201
Transcription Factor HIF1A Hypoxia-inducible factor 1 alpha Q16665 CHEMBL4261
Transcription Factor TP53 Cellular tumor antigen p53 P04637 CHEMBL4096
Unclassified HTT Huntingtin P42858 CHEMBL5514
Unclassified LMNA Prelamin-A/C P02545 CHEMBL1293235
Enrichment of Gene Ontology of Target Proteins (Activity≤10μM)


Detailed Information of Enriched Gene Ontolgy
GO Type GO Category Enriched GO Terms p-Value Adjusted p-Value Enriched Genes
BP GO:0008152; metabolic process GO:0097267; omega-hydroxylase P450 pathway 1.595E-12 3.102E-08 CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9
MF GO:0005488; binding GO:0019825; oxygen binding 6.436E-11 2.247E-07 CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9, NOX4
MF GO:0005488; binding GO:0005506; iron ion binding 9.318E-11 2.536E-07 ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9, XDH
BP GO:0008152; metabolic process GO:0019373; epoxygenase P450 pathway 1.273E-10 2.771E-07 CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9
MF GO:0005488; binding GO:0020037; heme binding 3.922E-08 3.882E-05 CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9, NOX4
BP GO:0008152; metabolic process GO:0016098; monoterpenoid metabolic process 6.740E-08 5.870E-05 CYP1A2, CYP2C19, CYP2C9
BP GO:0050896; response to stimulus GO:0042738; exogenous drug catabolic process 7.367E-07 4.456E-04 CYP1A2, CYP2C19, CYP2C9
BP GO:0050896; response to stimulus GO:0033993; response to lipid 9.570E-07 5.343E-04 AR, CA2, CYP1A1, CYP1A2, ESRRA, FLT3, HSD17B2, TP53, TYR
MF GO:0003824; catalytic activity GO:0004089; carbonate dehydratase activity 1.519E-06 7.875E-04 CA12, CA2, CA7
BP GO:0008152; metabolic process GO:2000377; regulation of reactive oxygen species metabolic process 5.768E-06 2.364E-03 CYP1B1, HIF1A, NOX4, TP53, XDH
BP GO:0008152; metabolic process GO:0009404; toxin metabolic process 5.863E-06 2.364E-03 CYP1A1, CYP1A2, CYP1B1
MF GO:0003824; catalytic activity GO:0070330; aromatase activity 5.863E-06 2.364E-03 CYP1A1, CYP1A2, CYP1B1
BP GO:0009987; cellular process GO:0032849; positive regulation of cellular pH reduction 6.989E-06 2.624E-03 CA2, CA7
BP GO:0032502; developmental process GO:0048513; animal organ development 7.317E-06 2.700E-03 AR, CA2, CYP1A1, CYP1A2, ESRRA, FLT3, HIF1A, HSD17B2, HTT, TYR
BP GO:0050896; response to stimulus GO:0010038; response to metal ion 8.227E-06 2.958E-03 ALOX15, CA2, CYP1A1, CYP1A2, HIF1A, TP53
BP GO:0009987; cellular process GO:0034599; cellular response to oxidative stress 1.128E-05 3.559E-03 AKR1B1, CYP1B1, DAPK1, NOX4, TP53
BP GO:0008152; metabolic process GO:0017144; drug metabolic process 1.292E-05 3.906E-03 ABCC1, AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9
BP GO:0008152; metabolic process GO:0018894; dibenzo-p-dioxin metabolic process 1.396E-05 4.001E-03 CYP1A1, CYP1A2
MF GO:0003824; catalytic activity GO:0034875; caffeine oxidase activity 1.396E-05 4.001E-03 CYP1A2, CYP2C9
BP GO:0008152; metabolic process GO:0006691; leukotriene metabolic process 1.476E-05 4.173E-03 ABCC1, ALOX15, ALOX5
BP GO:0009987; cellular process GO:2001237; negative regulation of extrinsic apoptotic signaling pathway 1.878E-05 5.076E-03 AR, DAPK1, HTT, LMNA
BP GO:0008283; cell proliferation GO:0042127; regulation of cell proliferation 1.890E-05 5.076E-03 AHR, AKR1B1, AR, CYP1B1, ESRRA, FLT3, HIF1A, LMNA, NOX4, TP53, XDH
MF GO:0003824; catalytic activity GO:0008395; steroid hydroxylase activity 1.958E-05 5.076E-03 CYP1A1, CYP2C19, CYP2C9
BP GO:0065007; biological regulation GO:0030003; cellular cation homeostasis 2.047E-05 5.243E-03 ABCG2, CA2, CA7, HIF1A, HTT, NPSR1, TP53
MF GO:0003824; catalytic activity GO:0009055; electron transfer activity 2.264E-05 5.667E-03 AKR1B1, CYP1A2, NOX4, XDH
BP GO:0008152; metabolic process GO:0006730; one-carbon metabolic process 2.332E-05 5.761E-03 CA12, CA2, CA7
BP GO:0008152; metabolic process GO:2001300; lipoxin metabolic process 3.484E-05 8.247E-03 ALOX15, ALOX5
BP GO:0051179; localization GO:0015701; bicarbonate transport 4.289E-05 9.831E-03 CA12, CA2, CA7
Enriched KEGG Pathways of Target Proteins (Activity≤10μM)


Top 10 KEGG Pathways (ordered by adjusted p-value)

Detailed Information of Enriched KEGG Pathways
Pathway Category Top Level Pathway Category Second Level Pathway ID Pathway Name p-Value Adjusted p-Value Enriched Genes
09150 Organismal Systems 09152 Endocrine system hsa04913 Ovarian steroidogenesis 1.081E-08 8.323E-07 HSD17B1, ALOX5, HSD17B2, CYP1A1, CYP1B1
09100 Metabolism 09103 Lipid metabolism hsa00140 Steroid hormone biosynthesis 2.318E-08 8.925E-07 HSD17B1, CYP1A2, HSD17B2, CYP1A1, CYP1B1
Unclassified Unclassified hsa01100 Metabolic pathways 9.019E-07 1.389E-05 CYP2C9, HSD17B1, ALOX5, HSD17B2, CYP1A2, ALOX15, CYP1A1, AKR1B1, CYP2C19, TYR, XDH
09100 Metabolism 09103 Lipid metabolism hsa00591 Linoleic acid metabolism 9.516E-08 2.442E-06 CYP2C9, CYP1A2, ALOX15, CYP2C19
09160 Human Diseases 09161 Cancers hsa05204 Chemical carcinogenesis 1.346E-07 2.592E-06 CYP2C9, CYP1A2, CYP1A1, CYP1B1, CYP2C19
09100 Metabolism 09103 Lipid metabolism hsa00590 Arachidonic acid metabolism 2.159E-06 2.375E-05 CYP2C9, ALOX5, ALOX15, CYP2C19
09100 Metabolism 09111 Xenobiotics biodegradation and metabolism hsa00980 Metabolism of xenobiotics by cytochrome P450 4.165E-06 4.009E-05 CYP2C9, CYP1A2, CYP1A1, CYP1B1
09150 Organismal Systems 09156 Nervous system hsa04726 Serotonergic synapse 2.282E-05 1.757E-04 CYP2C9, ALOX5, ALOX15, CYP2C19
09100 Metabolism 09105 Amino acid metabolism hsa00380 Tryptophan metabolism 2.898E-05 2.029E-04 CYP1A2, CYP1A1, CYP1B1
09160 Human Diseases 09161 Cancers hsa05200 Pathways in cancer 2.844E-04 1.460E-03 AR, FLT3, DAPK1, HIF1A, TP53
09160 Human Diseases 09161 Cancers hsa05230 Central carbon metabolism in cancer 1.367E-04 8.099E-04 FLT3, TP53, HIF1A
09100 Metabolism 09108 Metabolism of cofactors and vitamins hsa00830 Retinol metabolism 1.249E-04 8.017E-04 CYP2C9, CYP1A2, CYP1A1
09100 Metabolism 09102 Energy metabolism hsa00910 Nitrogen metabolism 2.042E-06 2.375E-05 CA12, CA2, CA7
09100 Metabolism 09111 Xenobiotics biodegradation and metabolism hsa00982 Drug metabolism - cytochrome P450 1.493E-04 8.209E-04 CYP2C9, CYP1A2, CYP2C19
09160 Human Diseases 09161 Cancers hsa05219 Bladder cancer 1.720E-03 8.277E-03 DAPK1, TP53
09130 Environmental Information Processing 09131 Membrane transport hsa02010 ABC transporters 1.979E-03 8.962E-03 ABCC1, ABCG2
09100 Metabolism 09110 Biosynthesis of other secondary metabolites hsa00232 Caffeine metabolism 2.169E-05 1.757E-04 CYP1A2, XDH
Human Diseases Associated with the Target Proteins of the Plant

Detailed Information of Human Diseases
ICD10 Disease Category Disease Name ICD10 Code Associated Disease Targets
(Association Ref: TTD database)
C00-D49: Neoplasms Melanoma C43 TYR;
L00-L99: Diseases of the skin and subcutaneous tissue Melasma L81.1 TYR;
NA: NA HIV infections NA AHR;
C00-D49: Neoplasms Multiple myeloma C90 AHR;
L00-L99: Diseases of the skin and subcutaneous tissue Vitiligo L80 TYR;
M00-M99: Diseases of the musculoskeletal system and connective tissue Rheumatoid arthritis M05-M06 TYR;
Data Section
Select to Download
1. General Info & Plant Usage & Geographical Distribution  
2. Human Target Proteins  
3. Target Gene Ontology  
4. Target KEGG Pathway  
5. Related Human Diseases  
>> Profiles of ingredients and activity landscape
>> Collective molecular activities profile at 10μM cutoff
>> Targets derived from weak experimental activities
About Us

The CMAUP database is developed by the Bioinformatics & Drug Design group (BIDD), which is based in the Department of Pharmacy, National University of Singapore, Singapore.

CMAUP

Home

About

Browse

Help

Useful links

BIDD home

NPASS database

TCM-ID database

TTD database

Contact

Singapore, 117549, National University of Singapore

Principle Investigator:
Prof. Chen Yu Zong
phacyz@nus.edu.sg

Developer & Maintainer:
Dr. Zeng Xian
zengxian@u.edu.nus

© 2018 Copyright: Bioinformatics & Drug Design group